Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.66 EUR | +0.66% | +1.73% | -2.24% |
May. 08 | Corella Resources Confirms High Purity Alumina Production | MT |
Apr. 29 | CAC40: France's rating maintained = non-event | CF |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With a 2024 P/E ratio at 27.79 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.24% | 11.9B | A- | ||
+20.68% | 84.31B | C+ | ||
-29.31% | 69.9B | B- | ||
+9.65% | 29.06B | C+ | ||
-8.63% | 17.38B | B | ||
+2.14% | 17.01B | A- | ||
+0.39% | 15.35B | A- | ||
+6.47% | 12.91B | B- | ||
+68.23% | 12.47B | C+ | ||
+6.43% | 12.26B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ERF Stock
- Ratings Eurofins Scientific SE